Tekla Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-12,029
| Closed | -$3.1M | – | 188 |
|
2021
Q2 | $3.1M | Hold |
12,029
| – | – | 0.1% | 142 |
|
2021
Q1 | $3.61M | Hold |
12,029
| – | – | 0.12% | 138 |
|
2020
Q4 | $3.07M | Sell |
12,029
-5,510
| -31% | -$1.4M | 0.11% | 143 |
|
2020
Q3 | $4.36M | Hold |
17,539
| – | – | 0.16% | 112 |
|
2020
Q2 | $6.09M | Hold |
17,539
| – | – | 0.23% | 89 |
|
2020
Q1 | $4.7M | Sell |
17,539
-1,373
| -7% | -$368K | 0.21% | 89 |
|
2019
Q4 | $6.12M | Hold |
18,912
| – | – | 0.23% | 91 |
|
2019
Q3 | $5.17M | Hold |
18,912
| – | – | 0.23% | 80 |
|
2019
Q2 | $10.1M | Hold |
18,912
| – | – | 0.41% | 57 |
|
2019
Q1 | $9.53M | Buy |
18,912
+12,620
| +201% | +$6.36M | 0.39% | 55 |
|
2018
Q4 | $3.1M | Sell |
6,292
-7,873
| -56% | -$3.88M | 0.13% | 106 |
|
2018
Q3 | $13M | Buy |
14,165
+1,580
| +13% | +$1.44M | 0.47% | 50 |
|
2018
Q2 | $9.22M | Buy |
12,585
+4,284
| +52% | +$3.14M | 0.35% | 66 |
|
2018
Q1 | $13.2M | Buy |
+8,301
| New | +$13.2M | 0.51% | 44 |
|
2014
Q4 | – | Sell |
-22,320
| Closed | -$4.04M | – | 96 |
|
2014
Q3 | $4.04M | Buy |
+22,320
| New | +$4.04M | 0.19% | 79 |
|